Helsinn says cytotoxics plant will be up and running in 2012
Swiss pharmaceutical ingredient maker Helsinn says its new cytotoxic API production plant will be operational for laboratory-scale projects early next year.
Archives for March 8, 2011
Ricerca enters 'strategic partnership' with Aptiv's Fulcrum Pharma
Ricerca Biosciences, a US-based preclinical contract research organisation (CRO) has announced it will enter a 'strategic partnership' with UK-based drug development consultants, Fulcrum Pharma.
Appointments at Quintiles, Synteract and MPI Research – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Quintiles, Synteract and MPI Research.
AZ halts pMDI Pulmicort production on inhaler's 'technical weakness'
AstraZeneca has announced it is discontinuing production of the pMDI version of its asthma drug Pulmicort due to technical issues with the drug's delivery device.
Thermo rolls out predictive liver toxicity assay
Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.
Wuxi signs ‘strategic’ small mol analysis deal with B-MS; plans new lab
Chinese CRO Wuxi PharmaTech will build a small molecule testing lab to service a new Bristol-Myers Squibb (B-MS) analysis contract.
GEA strikes Scandinavian representation deal with Christian Berner
GEA Pharma Systems, the German drug processing equipment manufacturer, has signed a representation agreement with Swedish hi-tech firm Christian Berner Tech Trade.